Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Phelan, M.
Right arrow Articles by Mirza, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Phelan, M.
Right arrow Articles by Mirza, I.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Family Practice Vol. 20, No. 2, 126-128
© Oxford University Press 2003

Clinical Research

The needs of patients receiving depot antipsychotic medication within primary care

Michael Phelan and Ilyas Mirzaa

Academic Centre, St Bernard’s Wing, Uxbridge Road, Middlesex UB1 3EU and
a Department of Psychiatry, Imperial College School of Medicine, London, UK.

Correspondence to Michael Phelan; E-mail: michael.phelan{at}wlmht.nhs.uk

Background. Depot antipsychotic medication is a vital treatment for many people with schizophrenia. Many patients receive this medication from primary care, and have little or no contact with specialist mental health services.

Objective. The aim of the present study was to compare the characteristics and needs of patients receiving depot medication within primary care with those receiving their medication from specialist mental health services.

Methods. A total of 58 patients were identified from four primary care teams. Data were collected from medical records, and staff interviews were conducted using standardized interview schedules.

Results. Patients receiving medication from primary care had more than twice as many health and social needs compared with those receiving medication from specialist services.

Conclusions. There are advantages for patients to receive depot medication from primary care, but the needs of the patients must be reviewed regularly, and primary care staff must have easy access to specialist mental health services.

Keywords. Depot antipsychotic, needs assessment, schizophrenia.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.